# Kura Oncology, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:a0efacbe-524c-4f0c-8c09-118fc6401d00 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/kura-oncology-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 33 | | Claims under review | 1 | | Evidence records | 8 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-07T06:07:41.580277+00:00 | | Last reviewed | 2026-10-07T06:07:41.580277+00:00 | ## Identity - Legal name: Kura Oncology, Inc. - Display name: Kura Oncology, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-07T17:11:50.036026+00:00 | | Completeness | 0.409 | | Record Quality | 0.83 | | Directors | 9 | | Committees | 4 | | Governance events | 9 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Brian Powl: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-10. claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:6 - Diane Parks: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. Committees: Compensation Committee (member); Nominating and Corporate Governance Committee (member). claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:8 - Helen Collins: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. Committees: Compensation Committee (member); Nominating and Corporate Governance Committee (member). claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:10 - Mary T. Szela: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. Committees: Audit Committee (member); Compensation Committee (member). claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:11 - Michael Vasconcelles: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-10. Committees: Compensation Committee (member). claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:12 - Carol Schafer: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:7 - Faheem Hasnain: Lead Independent Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:9 - Thomas Malley: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:13 - Troy E. Wilson: Chairman, President and Chief Executive Officer. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: President and Chief Executive Officer (chair). claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:5 ## Committees - Audit Committee (audit). Chair: NOT_PUBLISHED. Members: Mary T. Szela (member, current); Mary T. Szela (member, unknown). committee_id=alpha:committee:kura-oncology-inc:audit-committee - Compensation Committee (compensation). Chair: NOT_PUBLISHED. Members: Diane Parks (member, current); Helen Collins (member, current); Mary T. Szela (member, current); Michael Vasconcelles (member, current); Diane Parks (member, unknown); Helen Collins (member, unknown); Mary T. Szela (member, unknown); Michael Vasconcelles (member, unknown). committee_id=alpha:committee:kura-oncology-inc:compensation-committee - Nominating and Corporate Governance Committee (nominating_governance). Chair: NOT_PUBLISHED. Members: Diane Parks (member, current); Helen Collins (member, current); Diane Parks (member, unknown); Helen Collins (member, unknown). committee_id=alpha:committee:kura-oncology-inc:nominating-and-corporate-governance-committee - President and Chief Executive Officer (executive). Chair: Troy E. Wilson. Members: Troy E. Wilson (chair, unknown). committee_id=alpha:committee:kura-oncology-inc:president-and-chief-executive-officer ## Executive leadership - Francis Burrows, Ph.D.: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:16 - Mollie Leoni, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:19 - Teresa Bair, J.D.: Chief Legal Officer and Secretary [GC]. Status: current. claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:21 - Troy E. Wilson, Ph.D., J.D.: Chairman, President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:23 - Brian Powl: Chief Commercial Officer. Status: unknown. claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:14 - Francis Burrows: Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:15 - Kathleen Ford: Chief Operating Officer [COO]. Status: unknown. claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:17 - Mollie Leoni: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:18 - Teresa Bair: Chief Legal Officer and Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:20 - Troy E. Wilson: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:22 ## Governance events - DIRECTOR_APPOINTED: Brian Powl seat on Kura Oncology, Inc., effective 2026-04-10. Effective: 2026-04-10. Detected: 2026-10-07T06:07:41.580277+00:00. event_id=alpha:event:director_appointed:c7zmwm - DIRECTOR_APPOINTED: Michael Vasconcelles seat on Kura Oncology, Inc., effective 2026-04-10. Effective: 2026-04-10. Detected: 2026-10-07T06:07:41.580277+00:00. event_id=alpha:event:director_appointed:c6wbqu - EXECUTIVE_APPOINTED: Francis Burrows, Ph.D. executive of Kura Oncology, Inc., effective 2026-04-10. Effective: 2026-04-10. Detected: 2026-10-07T06:07:41.580277+00:00. event_id=alpha:event:executive_appointed:1dopjv6 - EXECUTIVE_APPOINTED: Mollie Leoni, M.D. executive of Kura Oncology, Inc., effective 2026-04-10. Effective: 2026-04-10. Detected: 2026-10-07T06:07:41.580277+00:00. event_id=alpha:event:executive_appointed:vev4r5 - GC_CHANGED: Teresa Bair, J.D. executive of Kura Oncology, Inc., effective 2026-04-10. Effective: 2026-04-10. Detected: 2026-10-07T06:07:41.580277+00:00. event_id=alpha:event:gc_changed:1efhu7y - CEO_CHANGED: Troy E. Wilson, Ph.D., J.D. executive of Kura Oncology, Inc., effective 2026-04-10. Effective: 2026-04-10. Detected: 2026-10-07T06:07:41.580277+00:00. event_id=alpha:event:ceo_changed:tilgz7 - DIRECTOR_APPOINTED: Helen Collins seat on Kura Oncology, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-07T06:07:41.580277+00:00. event_id=alpha:event:director_appointed:i3o3c3 - DIRECTOR_APPOINTED: Diane Parks seat on Kura Oncology, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-07T06:07:41.580277+00:00. event_id=alpha:event:director_appointed:1nwgl03 - DIRECTOR_APPOINTED: Mary T. Szela seat on Kura Oncology, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-07T06:07:41.580277+00:00. event_id=alpha:event:director_appointed:b3bj55 ## Scoped resources - `alpha://company/kura-oncology-inc` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record - `alpha://company/kura-oncology-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=identity - `alpha://company/kura-oncology-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=corporate-structure - `alpha://company/kura-oncology-inc/board` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=board - `alpha://company/kura-oncology-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=committees - `alpha://company/kura-oncology-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=leadership - `alpha://company/kura-oncology-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=ownership - `alpha://company/kura-oncology-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=financials - `alpha://company/kura-oncology-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=capital-structure - `alpha://company/kura-oncology-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=compensation - `alpha://company/kura-oncology-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=governance - `alpha://company/kura-oncology-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=shareholder-governance - `alpha://company/kura-oncology-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=audit - `alpha://company/kura-oncology-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=legal - `alpha://company/kura-oncology-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=risk - `alpha://company/kura-oncology-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=cyber - `alpha://company/kura-oncology-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=ai-governance - `alpha://company/kura-oncology-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=agents - `alpha://company/kura-oncology-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=ecosystem - `alpha://company/kura-oncology-inc/events` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=events - `alpha://company/kura-oncology-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=relationships - `alpha://company/kura-oncology-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=assessments - `alpha://company/kura-oncology-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:mary-t-szela-kura","name":"Mary T. Szela"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:diane-parks-kura","name":"Diane Parks"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:helen-collins-kura","name":"Helen Collins"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_appointment:29: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:mary-t-szela-kura","name":"Mary T. Szela"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:michael-vasconcelles-kura","name":"Michael Vasconcelles"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_appointment:32: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:diane-parks-kura","name":"Diane Parks"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_appointment:33: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:helen-collins-kura","name":"Helen Collins"},"source_id":"governance_people_committees"}` ## Leadership - Troy E. Wilson: Chairman, President and Chief Executive Officer. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5cba6fb1868838d0f21aa62d9342c50d736cf83588ee3de0ce1180c27b47e811. - Brian Powl: Director. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:6. Valid from: 2026-04-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b061cd10f0fb1c721852c613d262d550935350469ef232c3316a759902eb20c0. - Carol Schafer: Director. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5cba6fb1868838d0f21aa62d9342c50d736cf83588ee3de0ce1180c27b47e811. - Diane Parks: Director. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:8. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b061cd10f0fb1c721852c613d262d550935350469ef232c3316a759902eb20c0. - Faheem Hasnain: Lead Independent Director. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5cba6fb1868838d0f21aa62d9342c50d736cf83588ee3de0ce1180c27b47e811. - Helen Collins: Director. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:10. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b061cd10f0fb1c721852c613d262d550935350469ef232c3316a759902eb20c0. - Mary T. Szela: Director. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:11. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b061cd10f0fb1c721852c613d262d550935350469ef232c3316a759902eb20c0. - Michael Vasconcelles: Director. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:12. Valid from: 2026-04-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b061cd10f0fb1c721852c613d262d550935350469ef232c3316a759902eb20c0. - Thomas Malley: Director. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5cba6fb1868838d0f21aa62d9342c50d736cf83588ee3de0ce1180c27b47e811. - Brian Powl: Chief Commercial Officer. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5cba6fb1868838d0f21aa62d9342c50d736cf83588ee3de0ce1180c27b47e811. - Francis Burrows: Chief Scientific Officer. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5cba6fb1868838d0f21aa62d9342c50d736cf83588ee3de0ce1180c27b47e811. - Francis Burrows, Ph.D.: Chief Scientific Officer. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:16. Valid from: 2026-04-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:09545d028036c4994113bde8cc1ca28c6f154390a31075cdcdb9026ca6877d87. - Kathleen Ford: Chief Operating Officer. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5cba6fb1868838d0f21aa62d9342c50d736cf83588ee3de0ce1180c27b47e811. - Mollie Leoni: Chief Medical Officer. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5cba6fb1868838d0f21aa62d9342c50d736cf83588ee3de0ce1180c27b47e811. - Mollie Leoni, M.D.: Chief Medical Officer. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:19. Valid from: 2026-04-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:618a76b3d83def0890ccec610a2c0f02c880677f8b0f40e02589af3bef628e68. - Teresa Bair: Chief Legal Officer and Secretary. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5cba6fb1868838d0f21aa62d9342c50d736cf83588ee3de0ce1180c27b47e811. - Teresa Bair, J.D.: Chief Legal Officer and Secretary. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:21. Valid from: 2026-04-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:42eabb790cb88bda4184fd3fa0fee119dbd2c53ffd67186426187af48f127245. - Troy E. Wilson: President and Chief Executive Officer. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5cba6fb1868838d0f21aa62d9342c50d736cf83588ee3de0ce1180c27b47e811. - Troy E. Wilson, Ph.D., J.D.: Chairman, President and Chief Executive Officer. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:leadership_role:23. Valid from: 2026-04-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:04c90cbb72e56d77fbf970d3d63ab49e39d0c49e5b5ad26dc09d55f6f3d73a84. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit Committee: Chair not stated; Members Mary T. Szela. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9cee8c2e5059660b27702a676dd53d6d1217c5648fbfebcf6f01cbe10e14bf27. - Compensation Committee: Chair not stated; Members Diane Parks; Helen Collins; Mary T. Szela; Michael Vasconcelles. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_record:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9cee8c2e5059660b27702a676dd53d6d1217c5648fbfebcf6f01cbe10e14bf27. - Nominating and Corporate Governance Committee: Chair not stated; Members Diane Parks; Helen Collins. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_record:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9cee8c2e5059660b27702a676dd53d6d1217c5648fbfebcf6f01cbe10e14bf27. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Kura Oncology, Inc.. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bc4a5d71fac5cad5999b71692d14dc4712cd40cbca2304161a703b2fd7ccb815. ## Entity Status - Public listing published. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bc4a5d71fac5cad5999b71692d14dc4712cd40cbca2304161a703b2fd7ccb815. ## Published Fact - US. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bc4a5d71fac5cad5999b71692d14dc4712cd40cbca2304161a703b2fd7ccb815. ## Committee Appointment - Mary T. Szela: member, Audit Committee. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9cee8c2e5059660b27702a676dd53d6d1217c5648fbfebcf6f01cbe10e14bf27. - Diane Parks: member, Compensation Committee. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9cee8c2e5059660b27702a676dd53d6d1217c5648fbfebcf6f01cbe10e14bf27. - Helen Collins: member, Compensation Committee. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9cee8c2e5059660b27702a676dd53d6d1217c5648fbfebcf6f01cbe10e14bf27. - Mary T. Szela: member, Compensation Committee. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9cee8c2e5059660b27702a676dd53d6d1217c5648fbfebcf6f01cbe10e14bf27. - Michael Vasconcelles: member, Compensation Committee. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9cee8c2e5059660b27702a676dd53d6d1217c5648fbfebcf6f01cbe10e14bf27. - Diane Parks: member, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_appointment:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9cee8c2e5059660b27702a676dd53d6d1217c5648fbfebcf6f01cbe10e14bf27. - Helen Collins: member, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:committee_appointment:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9cee8c2e5059660b27702a676dd53d6d1217c5648fbfebcf6f01cbe10e14bf27. ## Security Listing - KURA (NASDAQ). Claim: alpha:claim:company:a0efacbe-524c-4f0c-8c09-118fc6401d00:security_listing:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bc4a5d71fac5cad5999b71692d14dc4712cd40cbca2304161a703b2fd7ccb815. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:bc4a5d71fac5cad5999b71692d14dc4712cd40cbca2304161a703b2fd7ccb815: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/kura-oncology-inc). - alpha:projection-evidence:document:5cba6fb1868838d0f21aa62d9342c50d736cf83588ee3de0ce1180c27b47e811: [SEC DEF 14A 0001193125-26-151335](https://www.sec.gov/Archives/edgar/data/1422143/000119312526151335/kura-20260410.htm). - alpha:projection-evidence:document:b061cd10f0fb1c721852c613d262d550935350469ef232c3316a759902eb20c0: [DEF 14A kura-20260410.htm](https://www.sec.gov/Archives/edgar/data/1422143/000119312526151335/kura-20260410.htm). - alpha:projection-evidence:document:09545d028036c4994113bde8cc1ca28c6f154390a31075cdcdb9026ca6877d87: [KURA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1422143/000119312526151335/kura-20260410.htm). - alpha:projection-evidence:document:618a76b3d83def0890ccec610a2c0f02c880677f8b0f40e02589af3bef628e68: [KURA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1422143/000119312526151335/kura-20260410.htm). - alpha:projection-evidence:document:42eabb790cb88bda4184fd3fa0fee119dbd2c53ffd67186426187af48f127245: [KURA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1422143/000119312526151335/kura-20260410.htm). - alpha:projection-evidence:document:04c90cbb72e56d77fbf970d3d63ab49e39d0c49e5b5ad26dc09d55f6f3d73a84: [KURA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1422143/000119312526151335/kura-20260410.htm). - alpha:projection-evidence:9cee8c2e5059660b27702a676dd53d6d1217c5648fbfebcf6f01cbe10e14bf27: [Audit Committee](https://www.sec.gov/Archives/edgar/data/1422143/000119312526151335/kura-20260410.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/kura-oncology-inc) - [Public Markdown](https://registry.alpha.ac/companies/kura-oncology-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/kura-oncology-inc?format=jsonld) - MCP resource: `alpha://companies/kura-oncology-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-07T17:11:50.037854+00:00; recorded 2026-10-07T17:11:50.037854+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.